Low-dose rate prostate brachytherapy is well tolerated in patients with a history of inflammatory bowel disease

Conclusions: Prostate brachytherapy is well tolerated in patients with a history of controlled IBD. Therefore, brachytherapy should be considered a viable therapeutic option in this patient population.